Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone808-326-1353
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$30.20 million
Profitability
Miscellaneous
Employees118
Next Earnings Date7/6/2020 (Estimated)
OptionableNot Optionable
Cyanotech (NASDAQ:CYAN) Frequently Asked Questions
What is Cyanotech's stock symbol?
Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."
How were Cyanotech's earnings last quarter?
Cyanotech Corp (NASDAQ:CYAN) posted its quarterly earnings results on Tuesday, February, 11th. The biotechnology company reported $0.03 EPS for the quarter. The biotechnology company had revenue of $7.50 million for the quarter. Cyanotech had a negative net margin of 4.12% and a negative return on equity of 7.93%. View Cyanotech's Earnings History.
When is Cyanotech's next earnings date?
Has Cyanotech been receiving favorable news coverage?
News articles about CYAN stock have trended somewhat positive on Friday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cyanotech earned a news impact score of 0.7 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Cyanotech.
Are investors shorting Cyanotech?
Cyanotech saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,100 shares, an increase of 133.3% from the January 15th total of 900 shares. Based on an average daily trading volume, of 3,400 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.1% of the company's stock are sold short. View Cyanotech's Current Options Chain.
Who are some of Cyanotech's key competitors?
What other stocks do shareholders of Cyanotech own?
Who are Cyanotech's key executives?
Cyanotech's management team includes the folowing people:
- Mr. Mawae R. Morton, Chief Exec. Officer (Age 52)
- Dr. Gerald R. Cysewski Ph.D., Co-Founder, Pres & Vice Chairman (Age 70)
- Mr. Brian Brett Orlopp, VP of Fin. & CFO and Sec.
- Mr. Glenn D. Jensen, VP of Manufacturing & Infrastructure (Age 61)
How do I buy shares of Cyanotech?
Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cyanotech's stock price today?
One share of CYAN stock can currently be purchased for approximately $2.12.
How big of a company is Cyanotech?
What is Cyanotech's official website?
How can I contact Cyanotech?
Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]
MarketBeat Community Rating for Cyanotech (NASDAQ CYAN)
MarketBeat's community ratings are surveys of what our community members think about Cyanotech and other stocks. Vote "Outperform" if you believe CYAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
